Vol 21 No 4 (2015)

Vol 21 No 4 (2015)

Published January 11, 2016

Commentary

Ananda Mohan Chakrabarty
US Supreme Court’s Decision on the Patent Ineligibility of Human Genes - BRCA1/BRCA2 as Products of Nature
PDF
Abhishek Kumar Yadav
Flavonoids – World Healthiest Gift for the Benefit of Human Health
Requires Subscription or Fee PDF
Peter J. Pitts, Robert Goldberg
Undermining Patient Values: The ASCO Value in Cancer Care Task Force Framework
Requires Subscription or Fee PDF

Articles

Andrew Henderson
Investment in Life Sciences in Scotland: Challenges and Opportunities
Requires Subscription or Fee PDF
Sholeh Azar, Timothy Ken Mackey
Crowdfunding: A New Untapped Opportunity for Biotechnology Start-ups?
Requires Subscription or Fee PDF
ajay gautam
EmergingCo: A Virtual “South-South” Biotech Model
PDF

Legal and Regulatory Updates

Peter J. Pitts
The FDA's Quality Revolution
Requires Subscription or Fee PDF
Denise Golgher, Roberto Rodrigues, Rodrigo Couto Massafera
Biosimilars in Brazil: developments in 2015 and business perspectives
Requires Subscription or Fee PDF